Automated Hematology Analyzer Market Size, Share, Trends and Outlook (2024-2031)

The global automated hematology analyzer market reached US$ 456 million in 2023 and is expected to reach US$ 795 million by 2031, growing with a CAGR of 7.2% during the forecast period 2024-2031.

Automated hematology analyzers are computerized, highly specialized machines that count the number of different types of red and white blood cells, blood platelets, hemoglobin, and hematocrit levels in a blood sample.

They include programmable automated alarm systems for indicating results outside the reference range. Hematology analyzers are concerned with the detection, and monitoring of diseases, prognosis, and subsequent screening and are extensively used against various blood-related diseases such as hemophilia, blood cancer, and blood clots. Other diseases include leukemia, anemia, blood transfusion, malignant lymphomas, and others where hematology diagnosis is used.